MNTA
Momenta Pharmaceuticals, Inc.
MNTA
MNTA
Delisted
MNTA was delisted on the 30th of September, 2020.
160 hedge funds and large institutions have $962M invested in Momenta Pharmaceuticals, Inc. in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 43 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
160
Holders Change
+5
Holders Change %
+3.23%
% of All Funds
4.01%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
26
Increased
56
Reduced
43
Closed
19
Calls
$1.76M
Puts
$53K
Net Calls
+$1.7M
Net Calls Change
+$298K
Top Buyers
| 1 |
O
1
OrbiMed
New York
|
$44.4M |
| 2 |
BFA
2
BlackRock Fund Advisors
San Francisco,
California
|
$90M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$86.7M |
| 4 |
OM
4
Opaleye Management
Boston,
Massachusetts
|
$4.97M |
| 5 |
SC
5
Samlyn Capital
New York
|
$3.97M |
